- Home
- FLGT
as of 12-12-2025 3:37pm EST
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | EL MONTE |
| Market Cap: | 697.3M | IPO Year: | 2016 |
| Target Price: | $28.33 | AVG Volume (30 days): | 265.4K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.40 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.57 - $31.04 | Next Earning Date: | 11-07-2025 |
| Revenue: | $315,549,000 | Revenue Growth: | 13.61% |
| Revenue Growth (this year): | 16.84% | Revenue Growth (next year): | 9.74% |
AI-Powered FLGT Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Fulgent Genetics Inc. (FLGT)
Chief Scientific Officer
Avg Cost/Share
$28.33
Shares
1,075
Total Value
$30,456.69
Owned After
952,890
SEC Form 4
Chief Scientific Officer
Avg Cost/Share
$29.57
Shares
943
Total Value
$27,884.04
Owned After
952,890
SEC Form 4
Chief Scientific Officer
Avg Cost/Share
$30.47
Shares
535
Total Value
$16,303.06
Owned After
952,890
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Gao Hanlin | FLGT | Chief Scientific Officer | Dec 2, 2025 | Sell | $28.33 | 1,075 | $30,456.69 | 952,890 | |
| Xie Jian | FLGT | President and COO | Dec 2, 2025 | Sell | $28.33 | 1,140 | $32,298.25 | 336,749 | |
| Gao Hanlin | FLGT | Chief Scientific Officer | Nov 28, 2025 | Sell | $29.57 | 943 | $27,884.04 | 952,890 | |
| Xie Jian | FLGT | President and COO | Nov 28, 2025 | Sell | $29.57 | 1,198 | $35,424.26 | 336,749 | |
| Gao Hanlin | FLGT | Chief Scientific Officer | Nov 24, 2025 | Sell | $30.47 | 535 | $16,303.06 | 952,890 | |
| Xie Jian | FLGT | President and COO | Nov 24, 2025 | Sell | $30.47 | 681 | $20,752.11 | 336,749 | |
| Xie Jian | FLGT | President and COO | Nov 19, 2025 | Sell | $29.10 | 10,000 | $290,983.00 | 336,749 |
Compare FLGT vs Leading Stocks
See how FLGT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "FLGT Fulgent Genetics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.